We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.105 | 2.26% | 4.755 | 4.52 | 4.99 | - | 189,060 | 16:35:30 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.36M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 04/8/2020 11:50 | Placing, yes, of course. Lol, keep hoping. | daveboy1 | |
| 04/8/2020 11:43 | Can I please join the other thread | tibbypip1 | |
| 04/8/2020 11:26 | No news? Its because there are lots of cogs moving behind the scenes IMO...clinical. regulatory, commercial planning and financing, possible deals and licensing discussions notwithstanding supplier dialogue....to be honest until near term directional aspects get crystallised then no news is what I would have expected...but could change any time from now so my tree may get "shaken" through ebbs and flows of various investors but I'm not getting "stirred". | elsol | |
| 04/8/2020 11:09 | This needs news. Amazing that since that first huge spike there's been no newsfow at all. No JVs, no licensing, no further trials, no takeover approach, no FDA fast-track approval, nada. And that with all authorities agreeing there's a second covid wave incoming any time in the next 3 or so months... | sloppyjoe2 | |
| 04/8/2020 11:02 | Lots of 10k and 15k buys going through today | tibbypip1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
